Everyone knows that the fall brings flu season, replete with aches, pains and a new version of the vaccine. But why is cold ...

As humans prepare for longer missions to the moon and Mars, scientists are trying to understand how space affects the human ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

Ionis Pharmaceuticals, Inc. shows promise with new drug launches and a robust pipeline. Click here to read IONS stock ...

How do stem cells know what to become?Nearly three decades after scientists isolated the first human embryonic stem cells, researchers are still ...

BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...

HUMANS could live for centuries after scientists have cracked the DNA code of the longest living mammal. The bowhead whale that can live for more than 200 years could hold the key to prolonging ...

Doctors are suddenly warning against a cheap 'autism drug' being fast-tracked to ease certain symptoms of the condition.

Type 1 diabetes (T1D) is a chronic autoimmune disease that results from the destruction of insulin-producing β-cells in the ...

According to neuroscientist Ben Rein’s new book, Why Brains Need Friends, it comes down to our brains. As he explains in the ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.